⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for neulasta®

Every month we try and update this database with for neulasta® cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian CancerNCT00113789
Ovarian Cancer
PI Discretion
18 Years - Amgen
Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian CancerNCT00113789
Ovarian Cancer
PI Discretion
18 Years - Amgen
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®NCT01735175
Neutropenic Com...
Breast Neoplasm...
Chemotherapy-in...
Chemotherapeuti...
LA-EP2006
Neulasta®
18 Years - Sandoz
Randomized Phase 2, Dose-finding Efficacy, Safety Study of ANF-RHO™ Versus Neulasta® in Chemotherapy-Induced NeutropeniaNCT03559387
Chemotherapy-in...
ANF-RHO™
Neulasta®
18 Years - Prolong Pharmaceuticals
Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC)NCT00094822
Lung Cancer
Non-Small Cell ...
PI Discretion
18 Years - Amgen
Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's LymphomaNCT00115193
Non-Hodgkin's L...
pegfilgrastim
pegfilgrastim
18 Years - Amgen
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®NCT01735175
Neutropenic Com...
Breast Neoplasm...
Chemotherapy-in...
Chemotherapeuti...
LA-EP2006
Neulasta®
18 Years - Sandoz
Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast CancerNCT03511378
Breast Cancer
Lupin's Pegfilg...
Neulasta®
18 Years - Lupin Ltd.
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-FilgrastimNCT01516736
Chemotherapy-in...
Breast Cancer
LA-EP2006
Neulasta®
18 Years - Sandoz
FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive ChemotherapyNCT00125723
Neutropenia
PI Discretion
18 Years - Amgen
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-FilgrastimNCT01516736
Chemotherapy-in...
Breast Cancer
LA-EP2006
Neulasta®
18 Years - Sandoz
Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC)NCT00094822
Lung Cancer
Non-Small Cell ...
PI Discretion
18 Years - Amgen
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®NCT01735175
Neutropenic Com...
Breast Neoplasm...
Chemotherapy-in...
Chemotherapeuti...
LA-EP2006
Neulasta®
18 Years - Sandoz
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®NCT01735175
Neutropenic Com...
Breast Neoplasm...
Chemotherapy-in...
Chemotherapeuti...
LA-EP2006
Neulasta®
18 Years - Sandoz
Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During ChemotherapyNCT00115206
Non-Small Cell ...
Neulasta® (pegf...
18 Years - Amgen
Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon CancerNCT00094809
Colon Cancer
Colorectal Canc...
Rectal Cancer
Placebo
Pegfilgrastim
18 Years - Amgen
Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC)NCT00094822
Lung Cancer
Non-Small Cell ...
PI Discretion
18 Years - Amgen
Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During ChemotherapyNCT00115206
Non-Small Cell ...
Neulasta® (pegf...
18 Years - Amgen
Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's LymphomaNCT00115193
Non-Hodgkin's L...
pegfilgrastim
pegfilgrastim
18 Years - Amgen
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: